Search
forResearch 10 of 1000+
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin
- Injury suppresses Ras cell competitive advantage through enhanced wild-type cell proliferation
- Commonalities Between COVID-19 and Radiation Injury
- Understanding Cancer Cells of Origin in Cutaneous Tumors
- Cutaneous adverse effects of targeted therapies
- Cyclin D3 deficiency inhibits skin tumor development, but does not affect normal keratinocyte proliferation
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- Is knowledge about the genetic and epigenetic alterations in melanoma a basis for targeted therapy?
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →